FDA Moves On Tekmira's Ebola Drug While Sarepta's Sits Unused
Sarepta's Ebola program getting more coverage. I don't think this would have happened if Sarepta hadn't spoken about it.
Maybe Ebola is what it takes for Sarepta's shorts to start covering?
Maybe there will be pressure on the DOD to restart the Sarepta Ebola and Marburg programs.
In the congressional hearing on Ebola yesterday there was repeated mention of Marburg too. There seems to be a sense of urgency now to make sure that we are protected for all viral hemorrhagic fevers.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.